Learn
AstraZeneca’s COVID-19 vaccine (AZD1222) was co-invented with the University of Oxford is in Phase 3 trials in the United States and has been approved for use in the United Kingdom.
Find the AstraZeneca COVID-19 vaccine information here.
Sanofi and GlaxoSmithKline have joined forces to start developing a COVID-19 vaccine and is tracking much later than other companies with phase 1/2 testing starting in early September and no efficacy data has been released so far.
Find the Sanofi and GSK COVID-19 vaccine information here.
Merck started developing its COVID-19 vaccine (V590) much later than other companies with phase 1/2 testing starting in early September and no efficacy data has been released so far.
Find the Merck COVID-19 vaccine information here.
Find the Novavax COVID-19 vaccine Information here.
The Janssen: Pharmaceutical Companies of Johnson & Johnson COVID-19 vaccine has been approved for Emergency Use Authorization by the FDA and will start rolling out in the United States as a Single Dose Covid-19 vaccine.
Find the Johnson & Johnson COVID-19 vaccine information here.
Moderna’s COVID-19 vaccine (mRNA-1273) finished Phase 3 and is approved for Emergency Use Authorization by FDA and is one of the two major vaccines being distributed in the United States and around the world.
Find the Moderna COVID-19 vaccine information here.
Pfizer has developed a COVID-19 vaccine, BNT162b2, along with and BioNTech SE that has concluded Phase 3 trials and has shown an efficacy rate of 95% in participants without prior SARS-CoV-2 infection. The vaccine is approved for use under the Emergency Use Authorization from the FDA.
Find the Pfizer COVID-19 vaccine information here.